Details for 2013849763
Up to date per 01.04.2026
Actions
Details for 2013849763
Granted/Registered
European Patent
14.10.2015 A
20.11.2019 B1
26.10.2012
SE
1251211
26.10.2012
US
201261719184 P
A61K 31/216 20060101AFI20160727BHEP
Owner
Oncopeptides Innovation ABLuntmakargatan 46111 37 StockholmSE
Representative
Representative
Weiser Voith Gugler Patentanwälte PartnerschaftKopfgasse 71130 WienAT
Inventor
SPIRA, JackNäsbyvägen 38 S-135 53 TyresöSE
LEHMANN, FredrikKanalvägen 61 SE-191 34 SollentunaSE
Information about Fees